BrightGene Bio-Medical Technology Co

BrightGene Bio-Medical Technology Co EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of BrightGene Bio-Medical Technology Co (688166.SS) as of Oct 8, 2026 is -160.45. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -1,782.56 — a change of -91.00% (higher).

EV/FCF

-160.45

YoY

-91.00%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of BrightGene Bio-Medical Technology Co is 2025 -160.45 . EV/FCF (Enterprise Value to Free Cash Flow) of BrightGene Bio-Medical Technology Co was 2024 -1,782.56 . It decreases by -91.00% higher compared to the previous year.

The BrightGene Bio-Medical Technology Co EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-395.65 CNY
Jan 1, 2019
-680.13 CNY
Jan 1, 2020
-96.38 CNY
Jan 1, 2021
-26.99 CNY
Jan 1, 2022
-49.97 CNY
Jan 1, 2023
-106.90 CNY
Jan 1, 2024
-1,782.56 CNY
Jan 1, 2025
-160.45 CNY
The BrightGene Bio-Medical Technology Co EV/FCF history
YEAREV/FCFYoY
-160.45-91.00%
-1,782.56+1,567.56%
-106.90+113.94%
-49.97+85.10%
-26.99-71.99%
-96.38-85.83%
-680.13+71.90%
-395.65-1.13%
-400.19-85.71%
-2,801.17—
Access this data via the Eulerpool API
Get Free API Key

BrightGene Bio-Medical Technology Co Stock analysis

What does BrightGene Bio-Medical Technology Co do? BrightGene Bio-Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BrightGene Bio-Medical Technology Co stock

EV/FCF (Enterprise Value to Free Cash Flow) of BrightGene Bio-Medical Technology Co is -160.45 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of BrightGene Bio-Medical Technology Co changed from -1,782.56 to -160.45, representing a -91.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) BrightGene Bio-Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s BrightGene Bio-Medical Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Valuation — BrightGene Bio-Medical Technology Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — BrightGene Bio-Medical Technology Co